Iqvia and scri collaborate to accelerate global oncology trials

Research triangle park, n.c.--(business wire)--iqvia (nyse:iqv), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, has announced a strategic collaboration with the contract research organization arm of sarah cannon research institute, scri development innovations, aimed at transforming oncology trials for biopharma partners worldwide. by combining the capabilities of iqvia and scri development.
IQV Ratings Summary
IQV Quant Ranking